Four subscribers allege Anthropic, OpenAI, SpaceXAI and Google violated federal antitrust law by coordinating to reduce the pace at which their competing artificial intelligence products improve.

By yourNEWS Media Newsroom.

A federal lawsuit accusing four major artificial intelligence companies of coordinating to slow improvements to their competing products is unfolding as the Trump administration signals that it wants the U.S. artificial intelligence industry to continue expanding.

President Donald Trump said Sept. 19 that he intends to establish an Artificial Intelligence Force aimed at supporting the industry’s development, comparing the proposed initiative with the creation of the U.S. Space Force during his first administration.

“I am forming the AI Force, much like I did Space Force, which has been a tremendous SUCCESS, in my First Term,” Trump said.

Trump also proposed replacing the term “artificial intelligence” with Superior Intelligence, Extreme Intelligence or Supreme Intelligence. On Sept. 20, he removed Supreme Intelligence from consideration after it drew less support in a poll, writing that the result was “probably because of its relationship to the Supreme Court.”

The developments followed a Sept. 18 lawsuit filed in the U.S. District Court for the Northern District of California against Anthropic, OpenAI, SpaceXAI and Google.

Four plaintiffs allege the companies reached an agreement to restrain the pace at which their competing AI systems improve. According to the complaint, the alleged arrangement affects subscribers paying for access to Claude, ChatGPT, Grok and Gemini.

The plaintiffs contend that customers purchase subscriptions partly because they expect continued access to increasingly capable models and regular technological improvements.

“The value of those subscriptions consists of access to Defendants’ most capable models and to the improvements Defendants continually release,” the complaint states.

“Defendants market and price those subscriptions on exactly that basis. An agreement that slows improvement lowers the quality of what subscribers receive for the price they pay.”

The case was filed less than a week after Anthropic CEO Dario Amodei called for slowing the development of increasingly powerful AI technology. OpenAI CEO Sam Altman, SpaceXAI CEO Elon Musk and Google DeepMind co-founder Demis Hassabis subsequently expressed support for Amodei’s proposal.

The plaintiffs argue that individual companies may independently decide to proceed more cautiously because of safety concerns but contend that competitors cannot lawfully coordinate with one another to limit the rate at which their products improve.

“An agreement among competitors to reduce the quality of their products and the rate at which those products improve is an agreement to restrict output,” the lawsuit states. “It is among the restraints Section 1 of the Sherman Act, 15 U.S.C. § 1, has always condemned, and it does not become lawful because the products are new.”

The Sherman Act prohibits contracts, combinations and conspiracies that unlawfully restrain trade. Federal antitrust law is intended to protect competition among businesses, including competition involving prices, products and quality.

The complaint does not argue that AI companies must develop their technology without safety precautions. Instead, the plaintiffs distinguish between decisions made independently by individual companies and what they allege would be a coordinated agreement among competitors.

Under their argument, Anthropic, OpenAI, SpaceXAI and Google remain free to establish their own safety standards, testing procedures and limitations without coordinating the pace of development with rival companies.

“Each Defendant is free, and indeed obligated, to set its own safety thresholds, retain its own evaluators, build its own product guardrails, and restrain its own development,” the lawsuit states. “None of that requires an agreement with rivals.”

The plaintiffs maintain that the distinction is important for customers who pay for AI subscriptions with the expectation that competing companies will continue independently trying to improve their products.

Their antitrust claim centers on the assertion that an agreement among rivals to reduce the pace of improvement would effectively restrict the output being offered to consumers, even if the companies say their motivation is improving safety.

The lawsuit therefore places two separate questions at issue: whether the companies actually entered into the alleged agreement and, if such an agreement existed, whether it constitutes an unlawful restraint of trade under the Sherman Act.

The plaintiffs contend that decisions about how quickly AI technology should advance should instead be made independently by each company or addressed through government policy rather than an agreement among competing businesses.

Trump’s announcement of an AI Force came one day after the lawsuit was filed and amid the broader debate over whether increasingly capable artificial intelligence systems should be developed more slowly because of potential safety risks. His announcement included few details about how the proposed body would be organized or operate.

The lawsuit, meanwhile, asks the federal court to address whether the AI companies crossed the line from separately considering safety precautions into coordinated conduct that the plaintiffs allege reduced competition and the value of the products for which subscribers paid.

Original article